Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Institute hosts Artistic Social Justice Week
2012-08-15

The International Institute for Studies in Race, Reconciliation and Social Justice at the university is hosting its first annual week of Artistic Social Justice from 23 to 31 August 2012. The week consists of performing arts activities such as plays, live music, poetry and an art exhibition.

In what is expected to become one of the annual highlights on the Kovsie calendar, students will have an opportunity to express themselves artistically while creating an awareness about social responsibilities.

Activities lined up for the week include the cabaret Vagina Dentata, a musical satire which looks at the unique stories of South African women. The line-up also include a lesbian, gay, bisexual, transgender and intersexed performance piece with participants giving oral narratives of issues affecting the LGBTIQ community.

The exhibition, The F-word: Images of forgiveness, tells the stories of people whose lives have been shattered by violence, tragedy and injustice and who are learning to forgive, reconcile and move on.

Paul Chappell, Research Consultant at the Centre for the Study of Aids at the University of Pretoria, will deliver a guest lecture on sexuality and disability.

For more information, contact Angelo Mockie at MockieSMA@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept